29023-48-1 Usage
Description
1-(tert-butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol is a complex organic compound with a unique chemical structure that features a tert-butylamino group, a morpholinyl group, and a 1,2,5-thiadiazol-3-yloxy group. This molecule is characterized by its potential pharmaceutical and therapeutic applications due to its diverse functional groups and chemical properties.
Uses
Used in Pharmaceutical Industry:
1-(tert-butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol is used as an active pharmaceutical ingredient for the development of various medications. Its unique chemical structure allows it to interact with specific biological targets, making it a promising candidate for the treatment of different medical conditions.
Used in Cardiovascular Applications:
In the pharmaceutical industry, 1-(tert-butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol is used as an antihypertensive agent to help lower blood pressure and reduce the risk of cardiovascular diseases. Its ability to regulate blood pressure makes it a valuable component in the development of antihypertensive medications.
Used in Cardiac Applications:
1-(tert-butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol is also used as an antiarrhythmic agent, particularly in the class II category, to help regulate abnormal heart rhythms and maintain a normal heartbeat. Its potential use in treating arrhythmias contributes to its importance in the development of cardiac medications.
Used in Angina Treatment:
1-(tert-butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol is used as an antianginal agent to help alleviate the symptoms of angina, a condition characterized by chest pain due to insufficient blood flow to the heart. Its role in improving blood flow and reducing chest pain makes it a valuable component in the treatment of angina.
Used in Ophthalmology:
In the field of ophthalmology, 1-(tert-butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol is used as an antiglaucoma agent to help reduce intraocular pressure and prevent optic nerve damage in patients with glaucoma. Its ability to manage intraocular pressure makes it a crucial component in the development of glaucoma treatments.
Used in Hemangioma and Vascular Anomaly Treatment:
1-(tert-butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol can be used to treat hemangioma and vascular anomalies due to its potential effects on blood vessels and its ability to regulate blood flow. Its application in this area highlights its versatility in addressing various medical conditions.
Chemical Properties:
1-(tert-butylamino)-3-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propan-2-ol is a white solid, which indicates its stability and suitability for use in various pharmaceutical formulations. Its solid-state properties contribute to its ease of handling and processing in the development of medications.
Check Digit Verification of cas no
The CAS Registry Mumber 29023-48-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,0,2 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 29023-48:
(7*2)+(6*9)+(5*0)+(4*2)+(3*3)+(2*4)+(1*8)=101
101 % 10 = 1
So 29023-48-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/i8D2,9D2,10D;
29023-48-1Relevant articles and documents
PROCESSES FOR THE PREPARATION OF 3,4-SUBSTITUTED-1,2,5-THIADIAZOLES AND INTERMEDIATES THEREOF
-
Page/Page column 9, (2009/07/03)
The present invention relates to intermediate compounds useful for the preparation of 1,2,5-thiadiazole compounds, including unsymmetrically substituted compounds such as 4-(3-secondary amino-2-hydroxy-propoxy)-1,2,5-thiadiazole compounds and azacyclic or azabicyclic 1,2,5-thiadiazole compounds and to processes for making the same.
Novel methods and compounds employed therein
-
, (2008/06/13)
Preparation of an optically active alkamine in the sinister configuration, or a derivative of said alkamine, which is reacted with an 3-X-4-chloro(or RO-- where R is hydrogen or an alkali metal)-1,2,5-thiadiazole to prepare S-3-X-4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazole beta adrenergic blocking agents. Novel 3-morpholino-4-chloro(or RO--)-1,2,5-thiadiazoles and their preparation also are described.
